Nanobiotix S.A. American Depositary Shares (NBTX) is a publicly traded Healthcare sector company. As of May 21, 2026, NBTX trades at $41.00 with a market cap of $2.40B and a P/E ratio of 0.00. NBTX moved +0.00% today. Year to date, NBTX is +106.61%; over the trailing twelve months it is +1018.13%. Its 52-week range spans $2.76 to $57.14. Analyst consensus is strong buy with an average price target of $34.33. Rallies surfaces NBTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Nanobiotix Halts Trading to Finalize €75 M Follow-On Offering Pricing: Nanobiotix halted trading of ordinary shares on Euronext Paris to finalize allocations and pricing for the €75 million follow-on offering. The €75 million offering includes US ADSs and European ordinary shares with pre-funded warrants, with 50–60% of proceeds for Nanoprimer, 30–40% for corporate needs and under 10% for JNJ-1900 development.
| Metric | Value |
|---|---|
| Price | $41.00 |
| Market Cap | $2.40B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $57.14 |
| 52-Week Low | $2.76 |
| Volume | 6.77K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
4 analysts cover NBTX: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $34.33.